[Epidemiology of Alzheimer's disease]
- PMID: 16396227
[Epidemiology of Alzheimer's disease]
Abstract
Because of global ageing of the population, the occurrence of Alzheimer's disease (AD) cases is increasing dramatically and AD is becoming a major public health preoccupation. By the year 2020, the World Health Organisation predicts that there will be almost 29 millions demented people throughout the world, two third of them being AD cases. This dramatic perspective could only be modified with new curative treatments or prevention. These last years, there is increasing evidence from epidemiological studies for the role of vascular risk factors in the aetiology of AD among which hypertension, type 2 diabetes, or high cholesterol. These potentially modifiable risk factors raise hope for prevention of Alzheimer's disease.
Similar articles
-
[Vascular risk factors and Alzheimer disease risk: epidemiological studies review].Psychol Neuropsychiatr Vieil. 2006 Mar;4(1):47-60. Psychol Neuropsychiatr Vieil. 2006. PMID: 16556518 Review. French.
-
[Alzheimer's disease and treatment of vascular risk factors].Ned Tijdschr Geneeskd. 2005 Dec 17;149(51):2844-9. Ned Tijdschr Geneeskd. 2005. PMID: 16398165 Review. Dutch.
-
[Perspective in the incidence of Alzheimer's disease in Austria by the year 2050].Wien Klin Wochenschr. 1992;104(20):631-5. Wien Klin Wochenschr. 1992. PMID: 1441561 German.
-
Burden of Alzheimer's disease: population-based estimates and projections for New Zealand, 2006-2031.Aust N Z J Psychiatry. 2008 Sep;42(9):828-36. doi: 10.1080/00048670802277297. Aust N Z J Psychiatry. 2008. PMID: 18696288
-
Risk and protective factors for sporadic Alzheimer's disease.Acta Virol. 2007;51(4):205-22. Acta Virol. 2007. PMID: 18197729 Review.
Cited by
-
An overview on therapeutics attenuating amyloid β level in Alzheimer's disease: targeting neurotransmission, inflammation, oxidative stress and enhanced cholesterol levels.Am J Transl Res. 2016 Feb 15;8(2):246-69. eCollection 2016. Am J Transl Res. 2016. PMID: 27158324 Free PMC article. Review.
-
Systematic Review of Basic Research on Alzheimer's Disease with Shen Zhi Ling Oral Liquid.Evid Based Complement Alternat Med. 2019 Apr 21;2019:8216714. doi: 10.1155/2019/8216714. eCollection 2019. Evid Based Complement Alternat Med. 2019. PMID: 31118971 Free PMC article. Review.
-
Variability in the diagnosis and management of patients with Alzheimer's disease and cerebrovascular disease: results from the GALATEA multicentre, observational study.Clin Drug Investig. 2008;28(7):429-37. doi: 10.2165/00044011-200828070-00004. Clin Drug Investig. 2008. PMID: 18544003
-
Neuroprotective and neurorescue effects of a novel polymeric nanoparticle formulation of curcumin (NanoCurc™) in the neuronal cell culture and animal model: implications for Alzheimer's disease.J Alzheimers Dis. 2011;23(1):61-77. doi: 10.3233/JAD-2010-101374. J Alzheimers Dis. 2011. PMID: 20930270 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical